{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:01:43Z","timestamp":1787997703551,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["No. 2016YFC0905000"],"award-info":[{"award-number":["No. 2016YFC0905000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["81522048"],"award-info":[{"award-number":["81522048"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["81573511"],"award-info":[{"award-number":["81573511"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["81472802"],"award-info":[{"award-number":["81472802"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["81273595"],"award-info":[{"award-number":["81273595"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012486","name":"Innovation Driven Project of Central South University","doi-asserted-by":"crossref","award":["2016CX024"],"award-info":[{"award-number":["2016CX024"]}],"id":[{"id":"10.13039\/501100012486","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jphs.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T09:12:45Z","timestamp":1543137165000},"page":"37-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The influence of telmisartan on metformin pharmacokinetics and pharmacodynamics"],"prefix":"10.1016","volume":"139","author":[{"given":"Jiagen","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meizi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2018.11.007_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jphs.2018.11.007_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12272-018-1039-x","article-title":"Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectives","volume":"41","author":"Liu","year":"2018","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jphs.2018.11.007_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.vhri.2016.10.005","article-title":"Induction of Type 2 diabetes mellitus with antihypertensive therapy: is there any role of alpha adducin, ACE, and IRS-1 gene?","volume":"12","author":"Gupta","year":"2017","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.jphs.2018.11.007_bib4","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1681\/ASN.2016121372","article-title":"Therapeutic considerations for antihyperglycemic agents in diabetic kidney disease","volume":"28","author":"Neumiller","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2018.11.007_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-8587(15)00379-4","article-title":"Diabetes and infection: assessing the association with glycaemic control in population-based studies","volume":"4","author":"Pearson-Stuttard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jphs.2018.11.007_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","article-title":"Diabetes and hypertension: the bad companions","volume":"380","author":"Ferrannini","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jphs.2018.11.007_bib7","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1056\/NEJMoa042274","article-title":"Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy","volume":"351","author":"Barnett","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jphs.2018.11.007_bib8","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1248\/bpb.b15-00577","article-title":"Effects of angiotensin II receptor blockers on metabolism of arachidonic acid via CYP2C8","volume":"38","author":"Senda","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jphs.2018.11.007_bib9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1248\/bpb.b17-00174","article-title":"The inhibitory effect of telmisartan on the metabolism of arachidonic acid by cyp2c9 and cyp2c8: an in\u00a0vitro study","volume":"40","author":"Kato","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jphs.2018.11.007_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/dmd.112.048264","article-title":"Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors","volume":"41","author":"Ren","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jphs.2018.11.007_bib11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00228-016-2130-1","article-title":"Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in\u00a0vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin","volume":"72","author":"Hu","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jphs.2018.11.007_bib12","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1124\/dmd.115.065748","article-title":"Organic anion transporter 1 is inhibited by multiple mechanisms and shows a transport mode independent of exchange","volume":"43","author":"Hotchkiss","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jphs.2018.11.007_bib13","doi-asserted-by":"crossref","first-page":"70752","DOI":"10.18632\/oncotarget.19984","article-title":"Pharmacokinetics and drug-drug interaction between enalapril, enalaprilat and felodipine extended release (ER) in healthy subjects","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jphs.2018.11.007_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00562061","article-title":"Pharmacokinetics of metformin after intravenous and oral administration to man","volume":"16","author":"Pentikainen","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jphs.2018.11.007_bib15","doi-asserted-by":"crossref","first-page":"4350712","DOI":"10.1155\/2016\/4350712","article-title":"The impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 polymorphisms on metformin therapeutic efficacy in Chinese type 2 diabetes patients","volume":"2016","author":"Xiao","year":"2016","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jphs.2018.11.007_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1124\/dmd.115.067223","article-title":"Effect of ondansetron on metformin pharmacokinetics and response in healthy subjects","volume":"44","author":"Li","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jphs.2018.11.007_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jphs.2016.04.016","article-title":"The effects of rabeprazole on metformin pharmacokinetics and pharmacodynamics in Chinese healthy volunteers","volume":"132","author":"Liu","year":"2016","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2018.11.007_bib18","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1177\/009127000004001202","article-title":"Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers","volume":"40","author":"Stangier","year":"2000","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jphs.2018.11.007_bib19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17425255.2010.494597","article-title":"Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties","volume":"6","author":"Deppe","year":"2010","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.jphs.2018.11.007_bib20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/clpt.2010.266","article-title":"Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants","volume":"89","author":"Cho","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jphs.2018.11.007_bib21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bcp.2005.09.011","article-title":"Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)","volume":"70","author":"Muller","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jphs.2018.11.007_bib22","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/dmd.107.015495","article-title":"Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine","volume":"35","author":"Zhou","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jphs.2018.11.007_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biopha.2017.08.041","article-title":"Telmisartan ameliorates adipoR1 and adipoR2 expression via PPAR-gamma activation in the coronary artery and VSMCs","volume":"95","author":"Shen","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jphs.2018.11.007_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/aps.2013.199","article-title":"Telmisartan protects central neurons against nutrient deprivation-induced apoptosis in\u00a0vitro through activation of PPARgamma and the Akt\/GSK-3beta pathway","volume":"35","author":"Pang","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jphs.2018.11.007_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2012.07.026","article-title":"Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: a possible link to anti-metabolic effects","volume":"692","author":"Shiota","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2018.11.007_bib26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2337\/db12-0570","article-title":"Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-delta activation","volume":"62","author":"Li","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2018.11.007_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1475-2840-11-139","article-title":"Telmisartan ameliorates insulin sensitivity by activating the AMPK\/SIRT1 pathway in skeletal muscle of obese db\/db mice","volume":"11","author":"Shiota","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jphs.2018.11.007_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jash.2014.05.006","article-title":"All-Literature Investigation of Cardiovascular Evidence G. A meta-analysis of randomized trials of telmisartan versus active controls for insulin resistance in hypertensive patients","volume":"8","author":"Takagi","year":"2014","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.jphs.2018.11.007_bib29","doi-asserted-by":"crossref","first-page":"e642","DOI":"10.1097\/MJT.0000000000000733","article-title":"Telmisartan improves insulin resistance: a meta-analysis","volume":"25","author":"Wang","year":"2018","journal-title":"Am J Therapeut"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861318302081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861318302081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:58:06Z","timestamp":1761163086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861318302081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1347861318302081"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2018.11.007","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of telmisartan on metformin pharmacokinetics and pharmacodynamics","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}